University of Cambridge Enterprise

University of Cambridge Enterprise

Give online
to University of Cambridge Enterprise

  • Cambridge Enterprise literature
    Cambridge Enterprise

University of Cambridge Enterprise works with members of the University to help them commercialise their research and provide consultancy services to industry.

In this current difficult economic climate it is even more important to support the efforts of innovators, and there is no more exciting place to do so than in Cambridge.

<p>Sir David Walker, Senior Advisor, Morgan Stanley International</p>

Cambridge Enterprise exists to transform brilliant technological and scientific concepts into commercial reality. Through academic consultancy, licensing of intellectual property and seeding new ventures, it brings together the UK's foremost academic inventors with experts from across the commercial spectrum.

Find out more

University of Cambridge Enterprise website

Gift announcements

Cambridge owes its world-leading excellence in research and teaching to the generosity of its supporters. Our history is synonymous with a history of far-sighted benefaction, and the same is as true today as it has ever been.

Gift announcement
LycaHealth, the new healthcare brand, have presented a donation of £150,000 to Cambridge University to support Sri Lankan students and improve public health in Sri Lanka.   
Gift announcement
Multi-million pound legacy to create a new 'Ray and Dagmar Dolby Court' at Pembroke College

Related impact stories

Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students received an unrivalled education.

Chris Lowe, Emeritus Professor (right) is pictured with David Holden-White
Philanthropic impact story
“Life sciences are the founding stone of entrepreneurship, the key to growing the economy and society” explains Darrin Disley, Chief Executive and Co-founder of Horizon Discovery Group, a translational genomics company credited with bringing about an era of personalised medicine.
Rebekah Scheuerle
Testimonial
Rebekah Scheuerle is a second-year Gates-Cambridge Scholar at St John’s College. She is undertaking a PhD in the BioScience Engineering Group in the Department of Chemical Engineering and Biotechnology.